Highlights:
- Despite successful trial results Moderna and AstraZeneca stocks dip
- BioXcel Therapeutics up by % post its phase successful trial of the therapeutic cure for bipolar disorder and schizophrenia
Last week at the US stock market was a mix. The market closed on Friday looking forward to earnings reports and the latest updates on the coronavirus trial results. As expected, Monday was a....
Tags : US stock market, Nasdaq, S&P 500, Dow Jones, Modera, AstraZeneca,
comments (0)